ACAN and Stroke: We have recently shown that 9 weeks of EE after stroke induce a further reduction in the number of these inhibitory molecules, especially Cat-315+ (aggrecan-containing) PNNs [12], supporting the idea that part of the peri-infarct and remote cortex possesses an environment for post-stroke response strategies [24].